Cargando…
Can heparin therapy reduce 28-day mortality in adult severe sepsis patients?
Autores principales: | Jiang, Li-bing, Ma, Yue-feng, Feng, Xia, Zhang, Mao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334613/ https://www.ncbi.nlm.nih.gov/pubmed/25879704 http://dx.doi.org/10.1186/s13054-015-0768-1 |
Ejemplares similares
-
Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis
por: Wang, Changsong, et al.
Publicado: (2014) -
Low-molecular-weight heparin therapy reduces 28-day mortality in patients with sepsis-3 by improving inflammation and coagulopathy
por: Zhang, Ze, et al.
Publicado: (2023) -
Activated protein C, severe sepsis and 28-day mortality
por: De La Torre-Prados, M, et al.
Publicado: (2012) -
An immune-related gene signature predicts the 28-day mortality in patients with sepsis
por: Peng, Yaojun, et al.
Publicado: (2023) -
Fentanyl- and midazolam-induced coma each influence days of mechanical ventilation and 28-day mortality
por: Tanios, Maged, et al.
Publicado: (2021)